These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 2742942
1. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients. Chang WH, Lin SK, Jann MW, Lam YW, Chen TY, Chen CT, Hu WH, Yeh EK. Biol Psychiatry; 1989 Jul; 26(3):239-49. PubMed ID: 2742942 [Abstract] [Full Text] [Related]
2. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M. Encephale; 1995 Jul; 21(6):417-24. PubMed ID: 8674466 [Abstract] [Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in guinea pigs. Chang WH, Jaw SS, Wu HS, Tsay L, Yeh EK. Psychopharmacology (Berl); 1988 Jul; 96(3):285-8. PubMed ID: 3146762 [Abstract] [Full Text] [Related]
4. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study. Chang WH, Lin SK, Jann MW. J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148 [Abstract] [Full Text] [Related]
5. Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment? Chang WH. Psychopharmacology (Berl); 1992 Apr; 106(3):289-96. PubMed ID: 1570373 [Abstract] [Full Text] [Related]
6. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients. Pan L, Vander Stichele R, Rosseel MT, Berlo JA, De Schepper N, Belpaire FM. Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444 [Abstract] [Full Text] [Related]
9. Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6. Young D, Midha KK, Fossler MJ, Hawes EM, Hubbard JW, McKay G, Korchinski ED. Eur J Clin Pharmacol; 1993 Oct; 44(5):433-8. PubMed ID: 8359179 [Abstract] [Full Text] [Related]
11. Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients. Someya T, Takahashi S, Shibasaki M, Inaba T, Cheung SW, Tang SW. Psychiatry Res; 1990 Feb; 31(2):111-20. PubMed ID: 2326392 [Abstract] [Full Text] [Related]
12. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population. Someya T, Suzuki Y, Shimoda K, Hirokane G, Morita S, Yokono A, Inoue Y, Takahashi S. Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685 [Abstract] [Full Text] [Related]
13. Reduced haloperidol and haloperidol: effects on homovanillic acid in caudate and prefrontal cortex. Chang WH, Wu HS, Tseng YT. Biol Psychiatry; 1987 Nov; 22(11):1369-74. PubMed ID: 3663789 [Abstract] [Full Text] [Related]